• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Higher Hematocrit Levels Are Associated with Increased Thrombosis Risk and Reduced Bleeding

May 10, 2017

A growing number of recent studies have observed an association between elevated hematocrit levels and thrombosis. However, the mechanism behind this pathway has remained elusive.  A recent study induced an elevation of hematocrit levels in otherwise healthy mice to tease apart the etiology of the thrombosis formation under increased RBC levels.  Compared with control mice, mice with elevated hematocrit had a shorter time to artery occlusion (13.2 vs 5.3 minutes, P<0.001) and reduced clotting time after tail transection.  Elevated hematocrit levels increased the time that platelets are in close proximity to a thrombus, thereby increasing the probability that they will become activated and part of the clot.  Whether venous thrombi form in a similar manner has yet to be determined, but this study highlights the importance of hematocrit levels on bleeding and thrombosis risk.

References:

Walton BL, Lehmann M, Skorczewski T, Holle LA, Beckman JD, Cribb JA, Mooberry MJ, Wufsus AR, Cooley BC, Homeister JW, Pawlinski R, Falvo MR, Key NS, Fogelson AL, Neeves KB, Wolberg AS. Elevated hematocrit enhances platelet accumulation following vascular injury. Blood 2017;129: 2537-46.

Machlus KR, Battinelli EM. RBCs pin platelets against the (thrombus) wall. Blood 2017;129: 2460-1

 

Filed Under

  • News
  • Platelet Transfusion
  • RBC Transfusion

Recommended

  • Updated FDA Guidance to Reduce the Risk of Transfusion-Transmitted Malaria

  • Coagulopathy in Patients with COVID-19—Interim Guidance from the International Society on Thrombosis and Haemostasis

  • Rh Alloimmunization Common Among Transfused Sickle Cell Patients

Show Comments

Reader Interactions

Comments

  1. Harold jackson says

    May 16, 2017 at 11:27 am

    Please citrate should not be used unless they are allergic to heparin there is also a lot of methods that are different that should be used which will promote a better outcome

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley